153 related articles for article (PubMed ID: 37390948)
1. Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
Raymond EG; Weaver MA; Shochet T; Grant M; Boyd K; Koenig LR; Upadhyay U
Contraception; 2023 Oct; 126():110109. PubMed ID: 37390948
[TBL] [Abstract][Full Text] [Related]
2. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
3. Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.
Young D; Fitzgerald K; Laursen L; Whitaker AK
Contraception; 2022 Nov; 115():62-66. PubMed ID: 35772525
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
5. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis.
Raymond EG; Weaver MA; Shochet T
Contraception; 2023 Nov; 127():110132. PubMed ID: 37517447
[TBL] [Abstract][Full Text] [Related]
7. Early abortion with buccal versus sublingual misoprostol alone: a multicenter, randomized trial.
Sheldon WR; Durocher J; Dzuba IG; Sayette H; Martin R; Velasco MC; Winikoff B
Contraception; 2019 May; 99(5):272-277. PubMed ID: 30831103
[TBL] [Abstract][Full Text] [Related]
8. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
9. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
el-Refaey H; Templeton A
Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
Blum J; Karki C; Tamang A; Shochet T; Shrestha A; Tuladhar H; Karki A; Sharma J; Abbas DF; Dragoman M; Winikoff B
Contraception; 2019 Dec; 100(6):451-456. PubMed ID: 31491379
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
Goldstone P; Walker C; Hawtin K
Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):366-371. PubMed ID: 28303569
[TBL] [Abstract][Full Text] [Related]
12. Medical methods for first trimester abortion.
Kulier R; Kapp N; Gülmezoglu AM; Hofmeyr GJ; Cheng L; Campana A
Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD002855. PubMed ID: 22071804
[TBL] [Abstract][Full Text] [Related]
13. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone and Misoprostol for Early Pregnancy Loss and Medication Abortion.
Macnaughton H; Nothnagle M; Early J
Am Fam Physician; 2021 Apr; 103(8):473-480. PubMed ID: 33856168
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and safety of two combined misoprostol regimens for second trimester medical abortion.
Kalogiannidis I; Tsakiridis I; Dagklis T; Kapetanios G; Mamopoulos A; Athanasiadis A
Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):42-47. PubMed ID: 33044101
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation.
Tang OS; Chan CC; Ng EH; Lee SW; Ho PC
Hum Reprod; 2003 Nov; 18(11):2315-8. PubMed ID: 14585880
[TBL] [Abstract][Full Text] [Related]
19. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
Guengant JP; Bangou J; Elul B; Ellertson C
Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
[TBL] [Abstract][Full Text] [Related]
20. A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.
Dzuba IG; Castillo PW; Bousiéguez M; Lugo Hernández EM; Castañeda Vivar JJ; Sanhueza Smith P
Contraception; 2020 Aug; 102(2):104-108. PubMed ID: 32474060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
